h¡wm¡−cn p¤fË£j ®L¡VÑ

q¡C−L¡VÑ ¢hi¡N (¢h−no j§m A¢d−rœ)

l£V ¢f ¢Vne ew 9105/2010

¢qEjÉ¡e l¡CVp Hä ¢fp gl h¡wm¡−cn (HCQBl¢f¢h) J AeÉ .......clM¡Ù¹L¡l£àuz

-he¡j-

h¡wm¡−cn plL¡l J AeÉ¡eÉ

 ..... fË¢afrNZz HÉ¡X−i¡−LV je¢Sm ®j¡l−pc pw−N

HÉ¡Xi¡LV ¢lfe h¡®~s

HÉ¡Xi¡LV p”u jäm

......clM¡Ù¹L¡l£à−ul f−rz

HÉ¡X−i¡−LV Hj, p¡CgE¢Ÿe ®M¡Le

---10-11ew fË¢afr f−r HÉ¡X−i¡−LV Ju¡−up Bm q¡l¦e£, ®Xf¤¢V HVeÑ£ ®Se¡−lm pw−N HÉ¡X−i¡−LV B−nL ®j¡¢je, ®Xf¤¢V HVe£Ñ ®Se¡−lm HÉ¡X−i¡−LV q~¢me Cje p¡q¡, pqL¡l£ HVe£Ñ ®Se¡−lm HÉ¡X−i−L¡V p¡ul¡ ¢g−l¡S, pqL¡l£ HVe£Ñ ®Se¡−lm HÉ¡X−i¡−LV j¡qg¥S¤l lqj¡e ¢mMe, pqL¡l£ HVeÑ£ ®Se¡−lm HÉ¡X−i¡−LV q¡¢gS¤l lqj¡e, pqL¡l£ HVe£Ñ ®Se¡−lm HÉ¡X−i¡−LV B¢gg¡ ®hNj, pqL¡l£ HVe£Ñ ®Se¡−lm HÉ¡X−i¡−LV m¡L£ ®hNj, pqL¡l£ HVe£Ñ ®Se¡−lm

.........l¡øÊ f−rz

Ef ¢ÙÛax

¢hQ¡lf ¢a ®j¡x Bnl¡g¥m L¡j¡m

Hhw

¢hQ¡lf¢a l¡¢SL Bm S¢mm

öe¡e£l a¡¢lM x 29.01.2020, 27.01.2021 Hhw l¡u

f Ëc¡−el a¡¢lM x 02.06.2022z    

¢hQ¡lf¢a ®j¡x Bnl¡g¥m L¡j¡mx

Kod Evf¡ceL¡l£ ®L¡Çf¡e£ ®jp¡pÑ ¢lX g¡jÑ¡ ¢mx Hl ¢ho¡š² fÉ¡l¡¢pV¡jm ¢pl¡f f¡e L−l

76 Se ¢nö jªa¥ÉhlZ L−lez ¢nö q¡pf¡a¡−ml avL¡m£e ¢LX¢e ¢h−no‘ X¡x q¡¢eg fÉ¡l¡¢pV¡j−m Eš² ¢ho ¢eZÑu L−lez 1992 p¡−ml 19®n ¢X−pðl j¡−p j¡jm¡ c¡−ul quz h¡wm¡−c−n ®p pju X¡C

Cb¡Cm NÔ¡CL¡m fl£r¡l k¿»f¡¢a e¡ b¡L¡u plL¡l£i¡−h ¢hnÄ ü¡ÙÛÉ pwÙÛ¡l j¡dÉ−j fl£r¡ Ll¡ q−u¢Rmz flhaÑ£−a 2007 p¡−m 28®n j¡QÑ q¡C−L¡−VÑl ¢e−cÑ−n Eš² j¡jm¡¢V f¤el¡u öl¦ quz flhaÑ£−a 2009 p¡−m Kod fÐn¡pe, e¡l¡ueN” XÊ¡N ®LCp ew- 02/2009 XÊ¡N Bc¡ma, e¡l¡ueN−” c¡−ul L−lez

1991 p¡−m j¡jm¡ c¡−u−ll 19 hvpl fl 2010 p¡−m kMe j¡jm¡l h¡c£ Bp¡j£−cl f−r

p¡rÉ fÐc¡e L−le aMe °c¢eL “pjL¡m” f¢œL¡ ®l¡hh¡l 9 L¡¢aÑL 1417, 24 A−ƒ¡hl 2010 a¡¢l−M “Kod fÐn¡pe i¥−m ®N−R 76 ¢nöl jªa¥Él k¿»e¡” ¢n−l¡e¡−j Seü¡−bÑ fТa−hce fÐL¡n L−lez Eš² fТa−hc−el ¢i¢š−a clM¡Ù¹L¡l£ ¢qEjÉ¡e l¡CVp Hä ¢fp gl h¡wm¡−cn (HCQBl¢f¢h) J AeÉ LaѪL NZfËS¡a¿»£ h¡wm¡−c−nl pw¢hd¡−el Ae¤−µRc 102(2) Hl Ad£e clM¡Ù¹ c¡¢M−ml ®fË¢r−a ¢hNa Cw−lS£ 03.11.2010 a¡¢l−M ¢hQ¡lf¢a −j¡q¡Çjc Cj¡e Bm£ Hhw ¢hQ¡lf¢a Jh¡uc¤m q¡p¡e pjeÄ−u Aœ ¢hi¡−Nl °àa ®h’ fË¢afrN−Zl Efl L¡lZ cnÑ¡−e¡f§hÑL ¢e−jÀ¡š² Ef¡−u l¦m¢V Cp¤É L−l¢Rmx-

“This application under Article 102 of the Constitution has been filed by Human Rights and Peace

for Bangladesh (HRPB) by way of a Public Interest Litigation (PIL) showing concern at the activities of

various authorities in relation to Drug Administration.

Mr. Manzill Murshid, learned advocate has

brought to our notice a report in the Samakal, a national newspaper published on 24.10.2010, which has made reference to the Drug Administration having forgotten

about death of 76 children who died after taking paracetamol syrup in the year 1991. The learned advocate points out that due to the negligence, inaction

and action taken with ulterior motive in order to frustrate

the prosecution of the persons involved in producing and supplying the paracetamol syrup, taking of which led to

the death 76 children in 1991. He points out that the newspaper article clearly shows that the officers concerned, who were at the time employed in the Drug Administration, have made differing statements in

relation to the case which has had the result of minimizing the possibility of any conviction in the case.

The learned advocate has also pointed out another newspaper article appearing in the Daily Inqilub on 24.08.2010, which relates to production and sale of substandard medicines and the inaction of the Drug Administration in monitoring the production and sale of medicines throughout the country. He has also referred to other incidents of maladministration in the provision of medicare to the citizens of this Country.

In view of the above submissions, we are inclined to issue a Rule.

The office is directed to register this application under Article 102 of the Constitution.

Let a Rule Nisi be issued calling upon the respondents to show cause as to why inaction of the respondents to take necessary steps to stop adulteration of drug or medical preparation, which is dangerous to the health of the citizens should not be declared illegal and without lawful authority and why a direction should not be given upon the respondents to take effective measures under section 25(C)of the Special Powers Act, 1974 in case of offence of adulteration of drug or medical preparation, and/or such other or further order or orders passed as to this Court may seem fit and proper.

The Rule is made returnable within 4(four) weeks

from date.

We are concerned that 76 children died in the year 1991 from taking paracetamol syrup and contradictory statements have been made by officials in connection with the prosecution of the case, and in the past 19 years the case has not been concluded for various reasons. We are not aware of the reasons for the delay in concluding the trial.

Hence, pending hearing of the Rule, we are inclined to issue the following directions.

1.                   The Secretary, Ministry of Health and Director General of Drug Administration are hereby directed to inquire into the matter and report to this Court within 1(one) month giving details of who has been involved in the prosecution of the case, what actions have been taken by the concerned officials, who started the case and were involved in investigating the matter on the part of the Drug Administration and prosecuting the case before the trial Court. In particular, the report is to disclose why such a delay of 19 years has taken place in bringing the case to a conclusion. In this regard respondent No.3 is also directed to report giving a chronological account of what steps had been taken in order to investigate case and to conclude the prosecution.
2.                The respondents No.1 and 2 is hereby directed to form a high power committee within 15 days consisting of all the respondents along with other experts in the filed to formulate monitoring guidelines in order to stop adulteration of drug or medical preparation;
3.             The respondents No. 1 and 2 also directed to collect sample of drug and medical preparations from (twenty different market places from the thana areas) in Dhaka city and conduct a laboratory test about the adulteration of drug or medical preparations, which causes health risk and submit report to this Court within six weeks.

4.               The respondents No. 6 and 7 are hereby directed to collect sample of drug and medical preparations from (twenty different market places from the thana areas) in Dhaka city and conduct a laboratory test about the adulteration of drug or medical preparations, which caused health risk and submit the report within six weeks; and
5.                 the respondent No.2 is directed to collect the activity reports of the last two years of the National Drug Advisory Council and the Drug Control Committee and submit the report to this Court within four weeks.

The respondent Nos. 1, 4, 6 and 7 are hereby directed to file affidavit in compliance within 6(six) weeks from date.

Let the matter appear in the list on 13.12.2010 for further orders.

Let the notice be served upon the respondents by FAX as well as by registered post at the cost of the office.”  

…l¦aÅf§ZÑ ¢hd¡u Aœ ®j¡LŸj¡l pLm B−cn ¢e−jÀ A¢hLm Ae¤¢mMe

q−m¡x

25.01.2011

Mr. Manzill Murshid, Advocate

-----For the Petitioner

Mr. Md. Motaher Hossain, D.A.G

----- For the Respondents On the prayer of the learned Deputy Attorney

General, this matter is adjourned till 27.01.2011.

B.O (Md. Imman Ali And

Sheikh Hassan Arif, J, J)

27.01.2011

Mr. M. A. Muntakim, Learned Advocate has filed a vokalatnama in court on behalf of the respondent No. 6 which is kept with the record.

B.O (Md. Imman Ali And

Sheikh Hassan Arif, J, J)

Present:

Mr. Justice Md. Imman Ali

And

Mr. Justice Sheikh Hassan Arif

27.01.2011

Mr. Manzill Murshid, Advocate

----- For the Petitioner. Mr. Md. Motaher Hossain, Deputy Attorney General with Mr. Samarendar Nath Biswas, Assistant Attorney General & Mr. Md. Jahangir Alam, Assistant Attorney General

----- For the respondents No. 1 & 2 Mr. Sheikh Awsafur Rahman, Advocate

----- For the respondents No. 5 & 7 Mr. Abdullah Al Bakee, Advocate

----- For the respondents No. 6 The respondents No. 6 and 7 have filed an affidavit

in compliance, which is kept with the record. They have indicated that since they do not have the necessary equipment for the purpose of testing, they could not comply with the directions of this Court.

The respondents No. 1 and 2  have filed an affidavit in compliance, which is dept with the record. The learned Deputy Attorney General has taken us through the affidavit giving details of what steps have been taken since the order of this Court dated 03.11.2010 in respect of formation of Committee, which is empowered to issue guidelines, and samples have been taken for testing quality. So far as the testing is concerned, respondents 1 and 2 have annexed as annexure- VI series reports of 173 samples of drugs taken from various locations. It transpires that the reports are dated from 17.01.2011 to 26.01.2011. It is to be noted that pursuant to the direction of this Court the tests were ordered in a meeting dated 09.01.2011, which was circulated on 25.01.2011. How tests could have been done on 17.01.2011 remains to be seen.

Be that as it may, from the report it is apparent that nine of the samples of medicine tested by the Drug Testing Laboratory are shown to be sub-standard. We note that these items include 1. Capsule- Tetracycline, North-Bengal Pharma Ltd. 2. Capsule-Indo-tetra. M/S Indo-Bangla Pharma Ltd., 3. Capsule-Dyclofenac- (Illegible) Enova Pharma Ltd, 4. Capsulre-N-D North- Bengal Pharma Ltd., 5. (Illegible) Tempil Alco Pharma Ltd., 6. (Illegible) Sepox, Alco Pharma Ltd., 7. Two (Illegible) of Capsule- BT Mox-500, (Illegible) Pharma Ltd., 8. Capsule- B (Illegible) Bengal Techno Pharma Ltd.

These items are all very common medicinal items prescribed everyday. We are not aware as to what action the concerned companies might have already taken in respect of the medicines (Illegible) have been found to the sub-standard. However, we are of the view that once identified as sub-standard they must immediately be taken off the shelf and must not be prescribed to any patient since they could endanger lives of patients.

We, therefore, direct the respondents No. 1 and 2 to take immediate steps of withdraw these items from the market. In this regard they may seek help from the law enforcing agencies including the police and Rapid Action Battalion (RAB). Respondent No. 3. Inspector General of Police (IGP) and respondent No. 4, Director General (DG) of RAB are hereby directed to provide all assistance to respondents No. 1 and 2 in order ensure that the sale of such drugs is (Illegible) and that all the drugs mentioned (Illegible) are immediately removed from all the (Illegible) and shops.

Respondent No. 1 and 2 are further (Illegible) to take immediate steps to prevent (Illegible) production and supply of the drugs mentioned above by the named drug manufacturing companies and to file compliance with regard to clearing the drug from all stores within Dhaka City within two weeks, and from all other stores elsewhere in the country within four weeks from date. The companies concerned may be permitted to manufacture/produce the drugs mentioned only after satisfying the required standard in accordance with law.

Let the matter appear in the list on 28.02.2011 for further orders.

Let the order be communicated by FAX as well as in the usual course immediately.

Sd/- Illegible

Sd/- Illegible

Present:

Mr. Justice Md. Imman Ali

And

Mr. Justice Sheikh Hassan Arif

17.02.2011

Mr. Shamsuddin Babul, Advocate

----- For the applicant. This is an application for addition of party as

respondent No. 9.

The learned advocate for the applicant submits that although the applicant was not a party to the writ petition, his products have been sized and manufacture has been stopped due to a report by the Drug Testing Laboratory, which was done consequent upon an order of this Court dated 27.01.2011. He submits that the applicant is, therefore, a necessary party for proper disposal of the Rue.

No one (Illegible) to oppose the application.

We find substance in the submissions of the learned Advocate, and for the reasons stated in the application for addition of party, the same is allowed.

Let the applicant be added as (Illegible) defendant No. 9.

(Illegible) office is directed to note (Illegible).

Sd/- Illegible Sd/- Illegible

20.03.2011

Present:

Mr. Justice Md. Ashfaqul Islam

And

Mr. Justice S. M. Emdadul Hoque

Mr. Manzil Murshid, Advocate

----- For petitioner. Mr. M. A. Muntakim, Advocate

----- Respondent No. 6 Let the application be kept with the record.

Let this matter be fixed for hearing on 24.04.2011 at the top subject to part heard.

Sd/- Illegible

Sd/- Illegible

24.04.2011

Present:

Mr. Justice Md. Ashfaqul Islam

And

Mr. Justice M. Moazzam Hussain

Mr. Manzil Murshid, Advocate

----- For the petitioner. Let this matter go out of list as this court has no

jurisdiction to hear the matter.

Sd/- Illegible

Sd/- Illegible

13.02.2017

Mr. Manzil Murshid, Advocate

----- For the petitioner. Let this matter be fixed for hearing tomorrow.

Sd/- Illegible

Sd/- Illegible

Present:

Mr. Justice Syed Muhammad Dastagir Husain

And

Mr. Justice Md. Ataur Rahman Khan

16.03.2017

Mr. Manzil Murshid, Advocate

----- For the petitioner. This is an application seeking for a direction upon

the respondent 1-2 to remove Md. Altaf Hossain, Deputy Director and Md. Shafiqul Islam, Assistant Director serving at present at Drug Administration from their post.

Heard the learned Advocate and perused the application.

Considering the facts and circumstance, the Respondent Nos. 1 and 2 is now directed to explain what action they have taken in view of the judgment and order passed in Drug Case No. 3 of 2009 and why they should not be removed from their respective services and to file report what step they have taken as per the order within 2 (two) weeks from the date of receipt of this Order.

The Notice is to be served upon the Respondents by special messenger at the Cost of the office.

Let it appears in the list on 06.04.2017 for further

order. 

Sd/- Illegible Sd/- Illegible

Present:

Mr. Justice Syed Muhammad Dastagir Husain

And

Mr. Justice Md. Ataur Rahman Khan

06.04.2017

Mr. Manzil Murshid, Advocate

----- For the petitioner.

Mr. Amit Talukder, D. A. G.

----- For the Respondent. Affidavit in compliance is filed in court today wherein it appears that the committee has been formed consisting of 5 members on 04.04.2017 but no date has been fixed for submission of report, as such the Respondent No. 1 is directed to fix a date to submit the report by the committee as constituted.

Let it appear in the list on 08.05.2017 for further

order.

Application for addition of party is kept with the record.

Sd/- Illegible Sd/- Illegible

08.05.2017

No one appears

----- For the petitioner.

Mr. Md. Jahangir Alam, A. A. G.

----- For the Respondents. As per order dated 06.04.2017 the committee was directed to submit report on the date fixed but as it appears no date has been fixed rather the member secretary of the inquiry committee has submitted that to

submit report it requires 16 weeks. In this connection the member secretary is directed to submit his report within 10 weeks from to-day i.e. within 18 July, 2017.

Let it appear in the list on 23.07.2017 for further order.

Sd/- Illegible Sd/- Illegible

Present:

Mr. Justice Syed Muhammad Dastagir Husain

And

Mr. Justice Md. Ataur Rahman Khan

03.08.2017

Mr. Manzil Murshid, Advocate

----- For the petitioner. Mr. Amit Talukder, D. A. G. with

Mr. Md. Jahangir Alam, A. A. G

----- For the Respondents. This is an application for not to accept the recommendation No. 1 of the Inquiry Committee report dated 11.07.2017.

Mr. Manzil Murshid, the learned Advocate appearing on behalf of the petitioner submits that the instant Writ Petition was filed for the purpose of public interest litigation under Article 102 of the Constitution of the Peoples Republic of Bangladesh challenging the inaction to take necessary steps to stop adulteration of drug or Medical preparation. He further submits that a Rule was issued upon the respondents and also an ad- interim order to form a high power committee to formulate monitoring guideline to stop adulteration of drug and medical preparations. He further submits that the Rule was issued arising out of a report about production and sale of adulterate medicine causing health risk to the citizen, 76 children were died due to

taking adulterated paracitamal syrup. Subsequently a case was started being Drug Case No. 03 of 2009 about the matter and as per direction, the Drug authority form a committee and submitted a compliance report and trial was concluded and Judgment was passed on 28.11.2016, wherein all the acused persons were acquitted with findings that both the accused persons, Superintendent, department of Medicine namely, Md. Shafiqul Islam and Md. Altaf Hossain are found to the extreme negligent incompetent and inefficient of their responsibilities. Both of them are serving under the Drug Administration authority, no departmental proceedings as yet been started against them, not they were removed from their post, not have taken any action/steps against those persons who are responsible for the death of such children. Under such circumstances, the instant application for not to accept the recommendation No. 1 and as to why the respondent Nos. 1 and 2 have not removed namely Superintendent, department of Medicine, namely, Md. Shafiqul Islam and Md. Altaf Hossainw who are serving under the Drug Administration authority.

Heard the learned Advocate for the petitioner, perused the application. It appears that there was a serious allegation that 76 children died due to taking adulterated Paracitamal syrup. There was a report by the Inquiry Committee submitted to the respondent Nos. 1 and 2 who have the responsibility to look into the matter and to take initiative of such adulteration. Despite of the report against Superintendent, Department of Medicine, Md. Shafiqul Islam and Md. Altaf Hossain are still serving under the Drug Administration authority though they were absolutely liable for such occurrence but the respondents did not take any steps against those persons.

Considering all these facts circumstances, the respondent Nos. 1 and 2 are directed to send a report within 3 (three) days from the date of receipt of this order, what actions have they taken against the persons

as named above.

Let it appear in the list on 13.08.2017.

Communicate the order at the cost of office. 

Sd/- Illegible

Sd/- Illegible

13.08.2017

j¡ee£u ®L¡−VÑl 03.08.2017 Cw a¡¢l−Ml B−cn ®j¡a¡−hL 1 J 2 ew ¢hh¡c£ hl¡hl kb¡l£¢a S¡l£ q−u−Rz S¡l£l fТa−hce fÐn¡p¢eL e¢b−a e¢bi¥š² Ll¡ q−m¡z

ü¡/- AØfø

13.08.2017

Mr. Manzil Murshid, Advocate

----- For the petitioner.

Mr. Amit Talukder, D. A. G.

----- For the Respondents. The learned Deputy Attorney General appearing

on behalf of the Respondents submits that he will file affidavit in compliance as such requires time.

In view of submission made by the learned Deputy Attorney General, let it appear in the list on 16.08.2017 for further order. 

Sd/- Illegible

Sd/- Illegible

21.08.2017

Mr. Manzil Murshid, Advocate

----- For the petitioner. Mr. Amit Talukder, D. A. G.

----- For the Respondents.

To-day the affidavit in compliance has been filed

by the learned Deputy Attorney General and it appears

that the respondent No. 1 the Secretary of Ministry of

Health, Bangladesh Secretariat has informed that Mr.

Md. Altaf Hosain and Mr. Md. Shafiqul Islam have been

warned by two memos dated 17.08.2017 and those have

been annexed as Annexure- 27, 28 & 29.

On this context the learned Advocate for the petitioner has submitted that the Secretary himself could

not understand what was the spirit of the Order. The

Order itself shows that 76 Children died due to taking adulterated Paracitamal syrup. There was a report by the

Inquiry Committee and the respondent Nos. 1 and 2 have

the responsibility to look into the matter and to take initiative of such adulteration and despite of such order

the Secretary of Health did not any take any responsibility nor any initiative against the two officers

Mr. Md. Altaf Hosain and Mr. Md. Shafiqul Islam. If Secretary himself could not understand the spirit of the

Order then he has to explain his position in this regard

by appearing before this Court and as such we direct the Respondent No. 1 Mr. Md. Shirajul Hoque Khan, the Secretary Ministry of Health and Family welfare, Bangladesh Secretariat. P. S. Shahagh, Dhaka to appear

in person to explain his position at 10.30 am positively

on 23rd August, 2016.

Office is directed to communicate the order immediately at the cost of the Office.

Sd/- Illegible

Sd/- Illegible

23.08.2017

j¡ee£u ®L¡−VÑl 21.08.2017 Cw a¡¢l−Ml B−cn 1ew ¢hh¡c£ hl¡hl kb¡l£¢a S¡l£ q−u−Rz S¡l£l fТa−hce fÐn¡p¢eL e¢b−a e¢bi¥š²

Ll¡ q−m¡z

ü¡/- AØfø

Present:

Mr. Justice Syed Muhammad Dastagir Husain

And

Mr. Justice Md. Ataur Rahman Khan

23.08.2017

Mr. Manzil Murshid, Advocate

----- For the petitioner. Mr. Qumrul Hoque Siddiqui, Advocate

----- For the Respondent No.1.

Mr. Amit Talukder, D. A. G with

Mr. Md. Jahangir Alam, A. A. G, and

Mr. Shafiqul Islam Siddique, A. A. G

----- For the Respondents. The Respondent No. 1 has personally appeared in

court to-day.

The Supplementary affidavit in compliance on behalf of the respondent No. 1 is not at all accepted as that has been sworned by an authorized person.

Thus the supplementary affidavit in compliance is rejected.

However, on the prayer of the learned advocate appearing on behalf of the Respondent No. 1 this matter is adjourned till tomorrow for filing affidavit in compliance in a proper way but the appearance is not dispensed with.

Sd/- Illegible

Sd/- Illegible

Present:

Mr. Justice Syed Muhammad Dastagir Husain

And

Mr. Justice Md. Ataur Rahman Khan

24.08.2017

Mr. Manzil Murshid, Advocate

----- For the petitioner.

Mr. Mahbubey Alam, Attorney General with

Mr. Amit Talukder, D. A. G.

----- For the Respondents. Mr. M. Qumrul Hoque Siddique, Advocate

----- For the Respondent No. 1. To-day the Respondent No. 1 is present and appeared before this court. He has filed further affidavit of compliance and also submits that already they have complied with the order and prayed for unconditional apology. 

Under such circumstances, the appearance of the respondent No. 1 is dispensed with.

The affidavit of compliance is accepted and be kept with the record.

Sd/- Illegible

Sd/- Illegible

Present:

Mr. Justice Syed Muhammad Dastagir Husain

And

Mr. Justice Md. Ataur Rahman Khan

17.10.2017

Mr. Manzil Murshid, Advocate

----- For the petitioner. This is an application filed on behalf of the petitioner for staying the order dated 28.09.2017 passed in Administrative Tribunal Case No. 314 of 2017 staying the order of suspension of Assistant Director Md. Shafiqul Islam and further direction upon the respondent No. 2 Md. Mustafizur Rahman to appear in person before this court on 23.10.2017 to explain his conduct.

The learned advocate for the petitioner submits that it is the case of Paracitamal Syrup where 76 child expired due to taking of adulterated paracitamal syrup. The Secretary Ministry of health passed an order of

suspension against Md. Shafiqul Islam, Assistant

Director and the matter is pending before this court. Md.

Shafiqul Islam, Assistant Director filed an Administrative

Tribunal Suit No. 2014 of 2017 challenging the suspension order dated 23.08.2017 and obtained an

order of stay and the Respondent No. 2 Md. Mustafizur Rahman, Director General, Drug Administration allowed

him to work knowing full well that a suspension order is

there and a proceeding is pending before this court a violation of order of this court.

Under such circumstances the order dated 28.09.2017 passed by Administrative Tribunal No. 1,

Dhaka being Case No. 314 of 2017 is stayed for a period

of 3 (three) months. The Respondent No. 2 Md. Mustafizur Rahman. Director General, Drug Administration is to explain his conduct as to why

knowing full well about the proceeding pending before

this court, he has permitted Md. Shafiqul Islam to work

as it appears from the order sheet-dated 04.10.2017

though the order of suspension has not been re-called.

He had to explain to the satisfaction before this court

within 7 days from the date of receipt of this order.

Let it appear in the list on 29.10.2017 for further

order.

Sd/- Illegible

Sd/- Illegible

29.10.2017

j¡ee£u ®L¡−VÑl 17.10.2017 Cw a¡¢l−Ml B−cn 2ew ¢hh¡c£ hl¡hl kb¡l£¢a S¡l£ q−u−Rz S¡l£l fТa−hce fÐn¡p¢eL e¢b−a l¡M¡ q−m¡z

ü¡/- AØfø

29.10.2017

Mr. Shah Munjurul Hoque, for

Mr. Abdul Matin Khasru, Advocate

----- For the Respondent No. 2. On the prayer of the learned Advocate for the Respondent No. 2 this matter is adjourned for 1 (one) week.

B. O. (Syed Md. Dastagir Husain And

        Md. Ataur Rahman Khan, J. J)

Present:

Mr. Justice Syed Muhammad Dastagir Husain

And

Mr. Justice Md. Ataur Rahman Khan

06.11.2017

Mr. Manzil Murshid, Advocate

----- For the petitioner. Mr. Abdul Matin Khasru, Senior Advocate with

Mr. Palash Chandra Roy, Advocate

----- For the Respondent No. 2. Mr. Amit Talukder, D. A. G.

----- For the respondents.

In pursuance of court’s order dated 17.10.2017, Md. Mustafizur Rahman, Director-General, Drug Administration, Motijheel Commercial Area, Dhaka as respondent No. 2 has filed an explanation through his engaged lawyer and begs Unconditional apology by annexing Annexure- X-4, wherein he stated that the delinquent personal is under suspension.

Considering the above facts and circumstances, affidavit sworn by Director-General, Drug Administration as respondent No. 2 Md. Mustafizur Rahman is hereby accepted.

Sd/- Illegible

Sd/- Illegible

Present:

Mr. Justice Syed Muhammad Dastagir Husain

And

Mr. Justice Md. Ataur Rahman Khan 16.11.2017

Mr. Manzil Murshid, Advocate

----- For the petitioner. Mr. Md. Zakir Hossain Masud, Advocate

----- For the applicants.

Mr. Md. Ariful Islam with

Mr. Mohammad Mijanur Rahman, Advocate

----- For the applicant-added respondent No. 10. Mr. Amit Talukder, D. A. G.

----- For the Respondents.

Mr. Md. Zakir Hossain Masud, the learned Advocate for the applicant of addition of party on behalf of (1) Md. Altaf Hossain, Deputy Director and (2) Md. Shafiqul Islam, Assistant Director, Directorate General of Drug Administration, Medicine Bhaban, Mohakhali, Dhaka submits that he has instructions not to press the application for addition of party, hence it is rejected as being not pressed.

Another application for addition of party as respondent No. 10 is filed by Mr. Md. Ariful Islam.

Mr. Md. Ariful Islam, the learned Advocate for the applicant submits that the applicant was not made a party in the instant writ petition and the applicant has got interest, as such, he is required to be added as a party as respondent No. 10 in the Writ Petition.

The learned Advocate for the Petitioner did not oppose the application for addition of party.

Heard the learned Advocates and perused the application.

Considering the facts and circumstances, since the applicant has got interest in the subject matter of this case, let the applicant be added as party.

Let the applicant Md. Shafiqul Islam, Assistant Director, Directorate of Drug Administration, Mohakhali, Dhaka be added as respondent No. 10 in the instant Writ Petition.

The office is directed to note accordingly.

Sd/- Illegible

Sd/- Illegible 06.12.2017

Mr. Mohammad Mijanur Rahman, Adv.

----- Respondent No. 10. The application for vacating the order of stay is

kept with the record.

B. O. (Syed Md. Dastagir Husain And

Md. Ataur Rahman Khan, J. J)

01.02.2018

Present:

Mr. Justice Syed Muhammad Dastagir Husain

And

Mr. Justice Md. Ataur Rahman Khan

Mr. Manzil Murshid, Advocate

----- For the petitioner.

Let the order of stay granted earlier by this court in administrative tribunal No. 1 Dhaka being Case No. 314/2017 be extended for a further period 6 (six) months from date of expiry.

Sd/- Illegible

Sd/- Illegible

23.07.2018

Present:

Mr. Justice Syed Muhammad Dastagir Husain

And

Mr. Justice Md. Iqbal Kabir

Mr. Manzil Murshid, Advocate

----- For the petitioner.

Let the order of stay granted earlier by this Court in case No. 314 /2017 of Administrative Tribunal No. 1, Dhaka be extended for a further period of 1 (one) year from date.

Sd/- Illegible

Sd/- Illegible 07.10.2018

Mr. Mohammad Mijanur Rahman, Adv

----- For the Respondent No. 10. Let this matter be fixed for hearing.

Sd/- Illegible

Sd/- Illegible 14.10.2018

Mr. Habibul Islam Bhuiyan with

Mr. Mohammad Mijanur Rahman, Adv

----- For the Respondent No. 10.

Heard in part.

B. O. (Syed Md. Dastagir Husain And

Md. Ataur Rahman Khan, J. J)

23.10.2018

On the prayer of the learned Advocate on behalf of the petitioner this matter is adjourned till 31.10.2018.

B. O. (Naima Haider

And

Khizir Ahmed Chowdhury, J. J)

01.11.2018

On the prayer of the learned Advocate on behalf of respondent, this matter is adjourned till 04.11.2018 as a last change.

B. O. (Naima Haider

And

Khizir Ahmed Chowdhury, J. J)

04.11.2018

Mr. Manzil Murshid with

Mr. Asaduzzaman Siddiqur, Advocate

----- For the petitioner. Mr. Mohammad Mijanur Rahman, Advocate

----- For the Respondent No. 10. Heard-in-part.

B. O. (Naima Haider

And

Khizir Ahmed Chowdhury, J. J)

11.11.2018

Mr. Manzil Murshid with

Mr. Asaduzzaman Siddiqur, Advocate

----- For the petitioner. Mr. Md. Habibul Islam Bhuiyan with

Mr. Mohammad Mijanur Rahman, Advocate

----- For the Respondent No. 10. For the respondent No. 10 let this matter be not

treated as in Heard-in-part.

Sd/- Illegible

Sd/- Illegible

Present:

Mr. Justice F. R. M. Nazmul Ahasan

And

Mr. Justice K. M. Kamrul Kader

07.02.2019

Mr. Mohammad Saifuddin Khokon, Advocate

----- For the applicant-petitioner.

This is an application for addition of party.

The application is not opposed.

Heard the learned Advocate and perused the application. For the reasons stated therein, we are inclined to allow the application. Accordingly, the application is allowed.

Let the applicant be added as Respondent No. 11.

Office is directed to do the needful in accordance with law.

Sd/- Illegible

Sd/- Illegible

30.04.2019

Mr. Mohammad Saifuddin Khokon the learned Advocate by power filed on behalf of the respondent No. 10 be kept record.

B. O. (F. R. M. Nazmul Ahsan And

K. M. Kamrul Kader, J. J)

30.04.2019

Mr. Manzil Murshid, Advocate

----- For the petitioner. Mr. Robiul Alam with

Mr. Mohammad Saifuddin Khokon, Advocate

----- For the Respondent No. 11. Let this matter go out of list for the time being.

Sd/- Illegible

Sd/- Illegible

Present:

Mr. Justice Moyeenul Islam Chowdhury

And

Mr. Justice Md. Ashraful Kamal

14.05.2019

Mr. Manzill Murshid, Advocate

----- For the petitioner-applicant.

On second thoughts, Mr. Manzill Murshid, learned Advocate appearing on behalf of the applicant, submits that he will not press the application dated 05.05.2019 for direction. Accordingly, the application is rejected as being not pressed.

Sd/- Illegible

Sd/- Illegible

14.07.2019

Mr. Manzill Murshid, Advocate

----- For the petitioner.

Let this matter be fixed for hearing on 28.07.2019.

Sd/- Illegible

Sd/- Illegible 18.07.2019

Mr. Manzill Murshid, Advocate

----- For the petitioners. Mr. Md. Robiul Alam (Budu), Advocate

----- For the respondent Nos. 10-11.

This is an application for issuance of a Supplementary Rule.

Having place the application, Mr. Manzill Murshid, learned Advocate for the petitioners submits that the petitioner filed the instant Writ Petition challenging the inaction of the respondents in taking necessary steps to stop adulteration of drug or medical preparation following the death of 76 children due to consumption of adulterated paracetamol syrup and other medicine of the same chemical composition, which gave rise to a criminal case, namely, Drug Case No. 03 of 2009 under section 16(a), (c) and section 17 of the Drug Control Ordinance, 1982 disposed of with the finding that the charges against the accused persons could not be proved due to the gross negligence, inefficiency and incompetence of respondent Nos. 10 and 11 and the copy of the said judgment was sent to the Secretary, Ministry of Health and Family Wealfare for information and taking necessary action, but upon drawing proceeding against them, the proceeding was disposed of with a minor penalty and subsequently, by the orders dated 31.03.2019 both of them have been reinstated in their service upon withdrawing the suspension order and they have been posted to their earlier posts and as such, in such facts and circumstances, the petitioner has filed the application for issuance of a Supplementary Rule as has been prayed for.

Mr. Md. Robiul Alam (Budu), learned Advocate for the respondent Nos. 10 and 11 submits that since a Criminal Appeal is pending against the judgment and order of acquittal passed in the said Drug Case No. 03 of 2009, the respondents should not be prejudiced in their service before disposal of the said Criminal Appeal inasmuch as the original Rule is pending before this Court for hearing and as such, the application may be disposed of along with the Rule.

We have perused the application along with the records of the Writ Petition as well as the judgment and order passed in Drug Case No. 03 of 2009 and heard the learned Advocates from both the sides.

In the facts and circumstances, we find substance in the submission of the learned Advocate for the petitioner, while we also find substance in the submission of the learned Advocate for the respondent Nos. 10 and 11 as to that pending disposal of the Criminal Appeal, they should not be prejudiced in their service. Accordingly, we are inclined to issue a Supplementary Rule.

Let a Supplementary Rule Nisi be issued calling upon the respondents to show cause as to why the office order dated 31.03.2019 bearing Memo No. 45.150.027.01.00.070.2018-245 (Annexure- D) and the office order dated 31.03.2019 bearing Memo No. 45.150.027.01.00.070.2018-246 (Annexure- D-1) issued by the respondent No. 1 should not be declared to have been passed without lawful authority and are of no legal effect and/or why such other or further order of orders as to this Court may seem fit and proper, shall not be passed.

Since it appears from the judgment and order passed in the said Drug Case No. 03 of 2009 that not only due to the gross negligence, inefficiency and incompetence of the respondent Nos. 10 and 11 the allegations were not proved, but both of them were Superintendent of Drugs at the time of the saddening death of 76 children, it is not prime facie safe to keep them in any charge of the Drug Administration till disposal of the Rule.

Accordingly, pending hearing of the Rule, the respondent Nos. 10 and 11 are hereby restrained from performing any function in connection with the affairs of the Drug Administration.

However, the respondent Nos. 1 and 2 may provide their service otherwise.

The Rule is made returnable within 2 (two) weeks from date.

Since the respondents have already made their appearance, there is no necessity for serving the Rule on them. 

Sd/- Illegible

Sd/- Illegible

Bf£m ¢hi ¡−Nl ¢hNa Cw−lS£ 13.10.2019 Hhw 09.12.2019 a¡¢l−Ml B−cnàu ¢e−jÀ A¢hLm Ae¤¢mMe q−m¡x

IN THE SUPREME COURT OF BANGLADESH APPELLATE DIVISION

Present:

Mr. Justice Syed Mahmud Hossain, Chief Justice

Mr. Justice Hasan Foez Siddique

Ms. Justice Zinat Ara

Mr. Justice Md. Nuruzzaman

CIVIL MISCELLANEOUS PETITION NO. 640 OF 2019 (From the order dated 18.07.2019 passed by the High Court Division in Writ Petition No. 9105 of 2010).

Md. Shafiqul Islam and another.

----- Petitioners.

-Versus-

Human Rights and Peace for Bangladesh (HRPB), represented by it’s President, Advocate Manzill Murshid and others.

----- Respondents.

For the Petitioners : Mr. Satya Ronjon Mondall,

Advocate-on-Record.

For Respondent No. 1 : Mr. Monzill Murshed,

Advocate instructed by Mr. Md. Nurul Islam Chowdhury, Advocate-on- Record.

Respondent Nos. 2-11 : Not represented.

Date of hearing : The 13th October 2019.

O R D E R

This is an application for vacating of the order of stay dated 23.07.2019 passed by the learned Judge-in- Chamber in Civil Miscellaneous Petition No. 640 of 2019.

Heard the learned counsel appearing for the applicant/respondent No. 1 and perused the application. Considering all aspects of the matter, we are inclined to vacate the order of stay passed by the learned Judge-in- Chamber. The order of stay dated 23.07.2019 passed by the learned Judge-in-Chamber is vacated.

Accordingly, the application is allowed.

Sd/- S. M. Hossain, C.J

Sd/- Hasan Foez Siddique, J Sd/- Zinat Ara, J

Sd/- Md. Nuruzzaman, J

IN THE SUPREME COURT OF BANGLADESH APPELLATE DIVISION

Present:

Mr. Justice Syed Mahmud Hossain, Chief Justice Mr. Justice Hasan Foez Siddique

Mr. Justice Md. Nuruzzaman

CIVIL PETITION FOR LEAVE TO APPEAL NO. 3118 OF 2019

(From the order dated 18.07.2019 passed by the High Court Division in Writ Petition No. 9105 of 2010).

Md. Shafiqul Islam and another.

----- Petitioners.

-Versus-

Human Rights and Peace for Bangladesh (HRPB), represented by it’s President, Advocate Manzill Murshid and others.

----- Respondents.

For the Petitioners : Mr. A. M. Aminuddin, Senior

Advocate instructed by Mr. Syed Mahbubar Rahman, Advocate-on-Record.

For Respondent No. 2 : Mr. Ruhul Quddus, Advocate

instructed by Mr. Md. Nurul Islam Chowdhury, Advocate- on-Record.

Respondent No. 1 & 3- : Not represented.

11

Date of hearing : The 09th December, 2019.

O R D E R

This petition for leave to appeal is directed against an interim order dated 18.07.2019 of the High Court Division in Writ Petition No. 9105 of 2010.

We have heard the learned counsel of both the parties and perused the impugned order of the High Court Division and the other materials on record. Upon hearing the parties, we are of the view that the ends of justice would be best served, if the Rule itself is disposed of on merit by the High Court Division.

Let the Rule be heard and disposed of by the Division Bench of the High Court Division presided over by Md. Ashraful Kamal, J., Expeditiously.

However, the operation of the order dated 18.07.2019 passed by the High Court Division in Writ Petition No. 9105 of 2010 so far it relates to restraining the respondent Nos. 10 and 11 from performing any function in connection with the affairs of the Drug Administration be stayed till disposal of the Rule.

The leave petition is disposed of with the above observations and directions.

Sd/- S. M. Hossain, C.J

Sd/- Hasan Foez Siddique, J

Sd/- Md. Nuruzzaman, J 06.01.2020

Mr. Manzill Murshid, Advocate

----- For the petitioner.

Let this matter be fixed for hearing on 20.01.2020.

Sd/- Illegible

Sd/- Illegible 29.01.2020

Mr. Manzill Murshid, Advocate

----- For the petitioner. Heard in part and adjourned to 10.02.2020

B. O. (Md. Ashraful Kama And                  Razik-Al-Jalil, J. J)

08.11.2020

frN−Zl B−hc−el ®fТr−a AcÉ ®j¡LŸj¡¢V öe¡e£ j¤mah£ Ll¡ qmz flhaÑ£ öe¡e£ 10.01.2021z

ü¡/- AØfø ü¡/- AØfø

27.01.2021

Mr. Manzill Murshid, Advocate

----- For the petitioner. Hearing concluded and judgment on 02.03.2021.

B. O. (Md. Ashraful Kama And                  Razik-Al-Jalil, J. J)

02.03.2021

Mr. Manzill Murshid, Advocate

----- For the petitioner. Judgment deferred to 07.04.2021.

B. O. (Md. Ashraful Kama And                  Razik-Al-Jalil, J. J)

21.06.2021

frN−Zl B−hc−el ®fТr−a AcÉ ®j¡LŸj¡¢Vl l¡u 1 pç¡−ql SeÉ j§mah£ Ll¡ q−m¡z

B−cnœ²−j

ü¡/- AØfø ü¡/- AØfø

29.06.2021

Mr. Manzill Murshid, Advocate

----- For the petitioner.

Judgment deferred to 06.07.2021.

B. O. (Md. Ashraful Kama And                  Razik-Al-Jalil, J. J)

20.01.2022

Mr. Manzill Murshid, Advocate

----- For the petitioner. Mr. Mohammad Saifuddin Khokon, Advocate

-----For the Opposite Party No. 10.

Judgment deferred to 20.02.2022.

B. O. (Md. Ashraful Kama And                  Razik-Al-Jalil, J. J)

clM¡Ù¹L¡l£ f−r ¢h‘ HÉ¡X−i ¡−LV j e¢Sm ®j ¡l−pc ¢hÙ¹¡¢lai ¡−h

k¤¢š²aLÑ EfÙÛ¡f e L−lez

Afl¢c−L  10  J  11ew  fË¢af r  f −r  ¢h‘  HÉ¡X−i ¡−LV  Hj

p¡CgE¢Ÿe ®M¡Le wjwLZ hyw³ `vwLj K‡ib hv wb‡æ AweKj AbywjLb n‡jx v

1|  AÎ ixU wcwUkbwU clM¡Ù¹L¡l£fr Avbqb Kivi ci MZ 03/11/10Bs

Zvwi‡L gnvgvb¨ nvB‡KvU© wefv‡Mi GKwU wWwfkb †e GB g‡g© l¦m Rvix K‡ib †h, †Kb bvMwiK‡`i Rb¨ r¢aLl  Jl‡a †fRvj wgkªY e‡Ü †imc‡W›U f−rl  wbw¯ŒqZv‡K A‰ea I rja¡h¢qi¥ÑÑa ejv hv‡e bv| GB g‡g© Av‡iv l¦m Rvix Kiv nq †h, †Kb Lv‡`¨ †fRv‡ji gZ Aciv‡ai Rb¨ we‡kl

rja¡  AvBb, 1974 Gi 25(wm) avivi weavb g‡Z e¨e¯ v’ †bIqvi Rb¨ †imcb‡W›UM‡Yi ¢hl¦−Ü e¨e¯ v’ †bIqv n‡e bv|

2|  ixU wcwUkb `vwL‡ji mgq ¯^xK…Zg‡ZB AÎ †imcb‡W›f Ur NZ−L fri¥š²

Kiv nq bvB wKsev AÎ †imcb‡W›UMY fri¥š² wQ‡jb bv| cieZ©x‡Z AÎ

frNZ fri¥š²  nb| Zvic‡i MZ 18/07/19 Bs Zvwi‡L nvB‡KvU© wefvM wb¤œwjwLZfv‡e m¤ú~iK l¦m wbwk Rvix K‡ib|

“ This is an application for issuance of a Supplementary Rule.

Having place the application, Mr.

Manzill Murshid, learned Advocate for the petitioners submits that the petitioner filed

the instant Writ Petition challenging the

inaction of the respondents in taking necessary steps to stop adulteration of drug

or medical preparation following the death

of 76 children due to consumption of adulterated paracetamol syrup and other

medicine of the same chemical composition,

which gave rise to a criminal case, namely,

Drug  Case  No.  03 of 2009 under section

16(a), (c) and section 17 of the Drug

Control Ordinance, 1982 disposed of with

the finding that the charges against the

accused persons could not be proved due to

the gross negligence, inefficiency and incompetence of respondent Nos. 10 and 11

and the copy of the said judgment was sent

to the Secretary, Ministry of Health and

Family Wealfare for information and taking

necessary action, but upon drawing proceeding against them, the proceeding was disposed of with a minor penalty and subsequently, by the orders dated 31.03.2019 both of them have been reinstated in their service upon withdrawing the suspension order and they have been posted to their earlier posts and as such, in such facts and circumstances, the petitioner has filed the application for issuance of a Supplementary Rule as has been prayed for.

Mr. Md. Robiul Alam (Budu), learned Advocate for the respondent Nos. 10 and 11 submits that since a Criminal Appeal is pending against the judgment and order of acquittal passed in the said Drug Case No. 03 of 2009, the respondents should not be prejudiced in their service before disposal of the said Criminal Appeal inasmuch as the original Rule is pending before this Court for hearing and as such, the application may be disposed of along with the Rule.

We have perused the application along with the records of the Writ Petition as well as the judgment and order passed in Drug Case No. 03 of 2009 and heard the learned Advocates from both the sides.

In the facts and circumstances, we find substance in the submission of the learned Advocate for the petitioner, while we also find substance in the submission of the learned Advocate for the respondent Nos. 10 and 11 as to that pending disposal of the Criminal Appeal, they should not be

prejudiced in their service. Accordingly, we

are inclined to issue a Supplementary Rule.

Let a Supplementary Rule Nisi be

issued calling upon the respondents to show

cause as to why the office order dated 31.03.2019 bearing Memo No. 45.150.027.01.00.070.2018-245 (Annexure- D)  and the office  order  dated 31.03.2019 bearing Memo No. 45.150.027.01.00.070.2018-246 (Annexure-

D-1) issued by the respondent No. 1 should

not be declared to have been passed without

lawful authority and are of no legal effect

and/or why such other or further order of

orders as to this Court may seem fit and

proper, shall not be passed.

Since it appears from the judgment

and order passed in the said Drug Case No.

03 of 2009 that not only due to the gross negligence, inefficiency and incompetence of

the respondent Nos. 10 and 11 the allegations were not proved, but both of

them were Superintendent of Drugs at the

time of the saddending death of 76 children,

it is not prime facie safe to keep them in any

charge of the Drug Administration till disposal of the Rule.

Accordingly, pending hearing of the

Rule, the respondent Nos. 10 and 11 are

hereby restrained from performing any

function in connection with the affairs of the

Drug Administration.”

3| D‡õ¢Ma m¤ú~iK l¦m wbwki mv‡_ A¿¹ha£ÑL¡m£e Av‡`‡ki gva¨‡g AÎ

†imcb‡W›UM‡Yi Kvh©µg †_‡K  weiZ _vKvi  wb‡`©k  cÖ`vb  Kiv nq  hv

cieZx© Civil Petition for Leave to Appeal No. 3118 of 2019

G cÖ`Ë MZ 09/12/2019Bs Zvwi‡Li Av‡`kg~‡j gnvgvb¨ nv‡ BKvU© wefv‡Mi D³ A¿¹ha£ÑL¡m£e Av‡`k ¯ w’ MZ K‡i gvgjvwU wb¯úwËi Rb¨ wePvicwZ Rbve ‡gvt Avkivdzj Kvgv‡ji †bZ…‡Z¡ MwVZ ˆØZ †e‡Â ïbvbx I wb¯úwËi Rb¨ †cÖiY K‡ib|

4| cÖv_wgK l¦−ml mgq AÎ †imcb‡W›UMY fr  wQ‡jb bv wKsev Zv‡`i ¢hl¦−Ü

†Kvb `vex-`vIqv wKsev †Kvb wb‡`©kbv PvIqv nqwb weavq cÖv_wgK l¦−ml

wel‡q AÎ †imcb‡W›UM‡Yi †Kvb e³e¨ bvB| Z‡e pÇf¤lL l¦m wbwk‡Z

AÎ †imcb‡W›U‡`i ¢hl¦−Ü cÖwZKvi PvIqv n‡q‡Q weavq AÎ †imcb‡W›UMY AÎ wjwLZ hyw³ZK© gnvgvb¨ Av`vj‡Z m`q we‡ePbvi Rb¨ †ck K‡i‡Q|

5|  pÇf¤lL l¦m wbwki g~j cÖwZcv`¨ welq n‡jv GB †h,MZ 21/07/2009 Bs

Zvwi‡L ixW dvg©v wjwg‡UW Gi cÖ¯ Z‘ K…ZT emset suspension (Paracetamol), Ridaplexsyp (Vitamin B Complex) Gi 4wU

bgybv  msMÖ‡ni  weavb  _vwK‡jI  Zviv  Zvnv msMÖ‡ni ‡Póv  bv K‡i  Amr D‡Ï‡k¨ WªvM AvB‡bi 23 aviv f½ K‡i miKvix Kg©Pvix (k„•Ljv I Avcxj)

bxwZgvjv, 1985 Gi 3(G) I 3(we) Gi AvIZvq Acra¡ I Am`vPib

Kivi c‡iI  La«Ñfr Zv‡`i‡K wefvMxq gvgjvi `vq n‡Z Ae¨vnwZ A−¿¹ wb¯úwË K‡ib| D³ wel‡q Av`vjZ‡K mš ó‘ Ki‡Z wM‡q ixU Av‡e`bKvix

fr  Av`vj‡Zi mvg‡b fzjfv‡e Dc¯ v’ cb K‡ib †h, AÎ †imcb‡W›Ufr−L

76 Rb wkïi g„Zz¨i `vq n‡Z KZr ©„c Ae¨vnwZ w`‡q‡Qb|

6| D³ Awf‡hv‡Mi wel‡q AÎ †imcb‡W›U Gi c−r `vqx GB †h 76 Rb wkïi

g„Zz¨i NUbvi K_v ejv nB‡Z‡Q †mB g„Zy¨i NUbv N‡UwQj 9 11 9 mv‡j A_P

AÎ †imcb‡W›UcrNZ Jla cÖkvm‡b WªvM Superintendent /Inspector

c‡` †hvM`vb K‡ib, h_v 24/03/1994 Ges 23/04/1996Bs Zvwi‡L, hv

D³ NUbvi A‡bK c‡i|

7| d‡j 76 Rb wkïi g„Zz¨i `vq †imcb‡W›U r c−L †Kvb µ‡gB `vqe× Kivi

my‡hvM bvB Ges †mB Kvi‡b wefvMxq gvgjvq Ae¨vnwZcÖvß AÎ †imcb‡W›UM‡Yi wel¦‡× e¨e¯ v’ †bIqviI †Kvb my‡hvM bvB| d‡j m¤ú~iK l¦m wbwk evwZj‡hvM¨|

8| bw_ `„‡ó cÖZxqgvb n‡e †h, AÎ ixU wcwUk‡b AvbxZ Awf‡hvMmg~‡ni mv‡_

AÎ †imcb‡W›Ucr cªZ¨r ev f−l¡ri¡−h †Kvb ms‡hvM bvB| Kvib 24/10/10 Bs Zvwi‡L cÖKvwkZ ˆ`wbK mgKv‡ji cÖwZ‡e`b Ges 21/07/10

Bs Zvwi‡L cÖKvwkZ ‰`wbK cÖ_g Av‡jvi cÖwZ‡e`b Ges 26/08/10 Bs

Zvwi‡Li ˆ`wbK BbwKjv‡ei cÖwZ‡e`b wKsev 1991 mv‡ji 76 Rb wkïi g„Zz¨i NUbvi mv‡_ AÎ †imcb‡W›UM‡Yi cªZr ¨ ev f−l¡ri¡−h †Kvb m¤úK© bvB| AÎ †imcb‡W›UMY 1994 mvj Ges 1996 mv‡j †hvM`vb K‡ib (Annexures-1,2,3  Ges 4  of Affidavit in Opposition of Respondent No. 10 and 11).

9| ixUKvixM‡Yi Kw_Z g‡Z 2009 mv‡j ixW dvg©vi GKwU Jla †me‡b wKQz

wkï g„Zy¨eib Kivq LaÑfr  21/06/09 Bs Zvwi‡L AÎ †imcb‡W›UcrNZ−L D³ Jla Gi bgybv msMÖ‡ni wb‡`©k w`‡j AÎ crNZ 21/07/09Bs Zvwi‡L XvKv wkï nvmcvZv‡j wM‡q D³ ixW dvg©v Gi Jl‡ai bgybv msMÖn K‡ib| †h‡nZz evRv‡i GKwU gvÎ †evZj cvIqv wM‡qwQj hv cvIqv wM‡qwQj ‡imcb‡W›UMY Lvb ZvB msMÖn K‡ib Ges Jla fl£r¡l j¨ve‡iUix‡Z IB w`bB cvVvb| j¨ve‡&iUix fl£r¡−¿¹ 29/07/09Bs Zvwi‡L

D³ Jl‡a †fRvj cvIqvq AÎ †imcb‡W›U fr  ixW dvg©vi ¢hl¦−Ü we‡kl

`vqiv RR Ges WªvM Av`vjZ, XvKv G WªvM gvgjv bs 03/09 `v‡qi K‡ib|

D³ gvgjvq we‡kl `vqiv RR Ges WªvM Av`vjZ, XvKv MZ 18/11/2016Bs Zvwi‡L Avmvgx‡`i Lvjvm cÖ`vb K‡ib (Annexure-5 I

6 of Affidavit in Opposition of Respondent No. 10 and

11)|  E−õ¢Ma Lvjvm Av‡`‡ki ¢hl¦−Ü AÎ †imcb‡W›U fr  Z_v miKvi

gnvgvb¨ nvB‡KvU© wefv‡M †dŠR`vix Avcxj bs 01/17 ` ‡qi K‡ib hv 09/03/17 Bs Zvwi‡L gnvgvb¨ nvB‡KvU© wefvM Admit K‡i‡Q| (Annexure-6A of Affidavit in Opposition of Respondent

No. 10 and 11)| D³ Avcxj gvgjvwU GL‡bv wePvivaxb Av‡Q|

10|  wePvwiK Av`vj‡Zi 28/11/16 Bs Zvwi‡Li Av‡`k‡K wbf©i K‡i, Avcxj

wePvivaxb GB K_v †Mvcb K‡i, AÎ ixU Av‡e`bKvix AÎ †imcb‡W›UfrNZ Gi wel¦−Ü e¨e¯ v’ †bIqvi Rb¨ gnvgvb¨ nvB‡KvU© wefv‡M AÎ ixU wcwUk‡b `iLvÙ¹ `v‡qi Kwi‡j gnvgvb¨ nvB‡KvU© wefvM weMZ 16/03/17Bs Zvwi‡L 1 I 2 bs †imcb‡W›U Gi cÖwZ GB g‡g© KviY `k©v‡bv †bvwUk Rvix K‡ib †h, WªvM gvgjv bs 03/09 Gi iv‡qi ci Zviv

AÎ †imcb‡W›U fr 10 I 11 bs Gi ¢hl¦−Ü wK e¨e¯ v’ wb‡q‡Qb Zvnv Rvbv‡Z e‡j‡Qb| D³ Av‡`‡ki ci 1 I 2 bs †imcb‡W›UMY 16/03/17

Bs Zvwi‡L AÎ †imcb‡W›UMY‡K KviY `k©v‡bvi †bvwUk Rvix Ki‡j AÎ †imcb‡W›UfrNZ 19/03/17Bs Zvwi‡L wb‡R‡`i‡K wb‡`©vl `vex K‡i Avcxj wb¯úwËi A‡cr¡u Av‡Q E−õM K‡i Reve cÖ`vb K‡ib

(Annexure-7 I 8 of Affidavit in Opposition of Respondent

No. 10 and 11)| AZ:ci 2bs †imcb‡W›U 5 (cuvP) m`m¨ wewkó GKwU Z`¿¹ KwgwU MVb K‡ib Ges D³ ac¿¹ KwgwU 11/07/17Bs Zvwi‡L Z`¿¹ cÖwZ‡e`b `vwLj K‡ib †hLv‡b AÎ †imcb‡W›UM‡Yi †Kvb Aciva cvqwb|

Z_vwcI Zviv †imcb‡W›Ucr−L mZK© Kivi Rb¨ mycvwik cÖ`vb K‡ib (Annexure-9 of Affidavit in Opposition of Respondent

No. 10 and 11)|

11| Gi cieZ©x‡Z D³ Z`¿¹ KwgwUi wi‡cv‡U©i Av‡jv‡K AÎ †imcb‡W›UM‡Yi

wel¦−Ü e¨e¯ v’ †bIqvi Rb¨ AÎ ixU Av‡e`bKvixMY AÎ gvgjvi 1 I 2 bs †imcb‡W›UM‡Yi wel¦−Ü wb‡`©kbv †P‡q `iLvÙ¹ `vwLj Kwi‡j gnvgvb¨ nvB‡KvU© wefvM 03/08/17Bs Zvwi‡Li Av‡`‡k 1 I 2 bs †imcb‡W›U Gi

wbKU GB g‡g© cÖwZ‡e`b Pvb †h, AÎ †imcb‡W›U Gi wel¦−Ü wK e¨e¯’v

†bIqv n‡q‡Q gnvgvb¨ nvB‡KvU© wefv‡Mi D³ wb‡`©kbvwU KZ©„cr 03/08/17Bs Zvwi‡L AÎ †imcb‡W›UM‡Yi wel¦−Ü mZK©Zvg~jK cÎ cÖ`vb

K‡ib Ges AvBbvbyMfv‡e fwel¨‡Z KvR Kivi wb‡`©k cÖ`vb K‡ib (Annexure-10  Ges 11 of Affidavit in Opposition of

Respondent No. 10 and 11)|

12| cieZ©x‡Z AÎ ixU Av‡e`bKvixi Av‡e`‡bi †c¢ Ör−a gnvgvb¨ nvB‡KvU© wefvM 21/08/17Bs Zvwi‡Li Av‡`k e‡j 2bs †imcb‡W›U†K ¯^kix‡i

nvwRi n‡q welqwU e¨vL¨v Kivi wb‡`©k †`b| D³ wb‡`©‡ki †c¢ªr−a 1bs †imcb‡W›U 21/08/17Bs Zvwi‡L AveviI AÎ †imcb‡W›UM‡Yi wel¦−Ü

KviY `k©v‡bv †bvwUk Rvix K‡ib †h, †Kb Zv‡`i wel¦−Ü miKvix PvKzix wewagvjv, 1985 Gi 3(K) I 3(L) Gi weavb g‡Z, Arja¡ I Am`vPib

wnmv‡e e¨e¯ v’ MÖnY Kiv n‡e bv| GKB mv‡_ AÎ †imcb‡W›Ucr−L mvgwqK

eiLvÙ¹ Kiv nq (Annexure-12, 13, 14 I 15 of Affidavit in

Opposition of Respondent No. 10 and 11)|

13| AÎ †imcb‡W›UMY 30/08/17 I 03/10/17Bs Zvwi‡L D³ Kvib `k©v‡bv †bvwU‡ki Reve †cÖiY K‡ib Ges GKB mv‡_ mvgwqK eiLv‡Ù¹l Av‡`k

P¨v‡jÄ K‡i cÖkvmwbK UªvBeybvj, XvKv‡Z cªkvmwbK UªvBeybvj gvgjv bs 324/17  `v‡qi  K‡ib  Ges  cÖkvmwbK  UªvBeybvj  28/09/17Bs  Zvwi‡Li

Av‡`k e‡j 23/08/17Bs Zvwi‡Li mvgwqK eiLv‡Ù¹l Av‡`k ¯ w’ MZ K‡ib|

d‡j AÎ †imcb‡W›UMY Zv‡`i PvKzix‡Z KvR Kiv ïl¦ K‡ib

(Annexure-16, 17  I 18 of Affidavit in Opposition of Respondent No. 10 and 11)|

14| cieZ©x‡Z ixU Av‡e`bKvix cÖkvmwbK UªvBeybv‡ji D³ 28/09/17Bs

Zvwi‡L  ¯ w’ MZv‡`k  ¯ w’ MZ  †P‡q  AÎ  ixU  gvgjvq  `iLvÙ¹  `vwLj  Kwi‡j

gnvgvb¨ nvB‡KvU© wefvM 17/10/17Bs Zvwi‡Li Av‡`kg~‡jZ vnv ¯ w’ MZ

K‡ib| Gi cieZx©‡Z 31/03/19Bs Zvwi‡L 1bs †imcb‡W›U cÎ gvidZ

Rvbvb †h, AÎ †imcb‡W›U†`i wel¦−Ü AvbxZ Awf‡hvM cÖgvwbZ nqwb ZvB Zv‡`i‡K Ae¨vnwZ †`b (Annexure-19 I 20 of Affidavit in Opposition of Respondent No. 10 and 11) Gi c‡iB m¤ú~iK

l¦m wbwk Av`vjZ nB‡Z cÖvß nq|

15|  GLv‡b D‡õMÉ †h, m¤ú~iK l¦m wbwk Rvixi Rb¨ 16/07/19Bs Zvwi‡L

`iLvÙ¹ `vwL‡ji c~‡e© weMZ 05/05/19Bs Zvwi‡L AÎ ixUKvixMY AÎ ixU wcwUk‡b GKwU `iLvÙ¹ `vwLj K‡i D³ 31/03/19Bs Zvwi‡Li Av‡`‡ki

Dci h_vh_ Av‡`k cÖv_©bv Ki‡j, gvbbxq wePvicwZ Rbve gCbyj Bmjvg

†PŠayix Ges gvbbxq wePvicwZ Rbve Avkivdzj Kvgvj Gi ˆØZ †e D³

`i M¡−Ù¹l Dci †Kvb Av‡`k w`‡Z A¯^xK…wZ Rvbvb GB Kvi‡b †h, vM W ª Av`vj‡Zi ivq Gi wel¦−Ü BwZg‡a¨B miKvi gnvgvb¨ nvB‡KvU wefv‡M Avcxj bs 01/17 `vwLj K‡i‡Qb| GB NUbvwU ixUKvixMY 16/07/19Bs

Zvwi‡Li `iM¡−Ù¹l 8bs c¨viv‡Z D‡õM Av‡Q|

16| weMZ 16/07/19Bs Zvwi‡Li `iM¡−Ù¹ ixU Av‡e`bKvix D−õM K‡ib †h, 76

Rb wkïi g„Zz¨i Rb¨ WªvM gvgjv bs-03/09 `v‡qi Kiv nq| wKš‘ g~j l¦m

wbwk 24/10/10Bs Zvwi‡Li ˆ`wbK mgKv‡ji wi‡cv‡U©i wfwˇZ cÖKvwkZ nq †hLv‡b my¯úófv‡e D−õM Av‡Q D³ 76 Rb wkï 1991 mv‡j gviv hvq|

17|  bw_ `„wó‡Z cÖZxqgvb nq †h, 2010 mvj †_‡K g~j ixU wcwUkbwU wb¯úwË bv

K‡i 2017 mvj †_‡K A`¨vewa ch¿ ©¹ ixUKvixMY D‡Ïk¨cÖ‡bvw`Z n‡q AÎ †imcb‡W›Uc−rl wel¦−Ü nqivwbg~jK wewfbœ `iM¡Ù¹ `v‡qi K‡i hv‡”Qb|

18|  E−õ¢Ma NUbv I cvwicvwk¦©K Ae¯ v’ i †cÖwr−a Bnv cÖZxqgvb nq †h, m¤ú~iK

l¦m¢Y MÖnY Kiv n‡q‡Q Ggb GKwU Awf‡hv‡Mi −fË¢r−a †h Awf‡hvMwU 76

Rb wkïi g„Zz¨i Rb¨ `v‡qi Kiv n‡q‡Q Ges ixUKvixM‡Yiv fl¨ g‡Z D³

gvgjvq AÎ †imcb‡W›UM‡Yi MvwdjwZi Kvi‡b Avm gxfr Lvjvm ‡c‡q

hvq| D³ Awf‡hvM hw` mZ¨I a‡i †bIqv nq Zvn‡jI GK_v wbwð‡¿¹ ejv

hvq †h, Awf‡hvM¸‡jv wg_¨v, wfwËnxb Ges KvMRcÎ Øviv mgw_©Z bq|

KviY 76 Rb wkï gviv wM‡q‡Q 1991 mv‡j hv mgKv‡ji cÖwZ‡e`‡b D‡õM

Av‡Q (Annexure-A series of Writ Petition) A_P AÎ

†imcb‡W›Ufr PvKzix‡Z †hvM`vb K‡ib 1994 I 1996 mv‡j (Annexure-1, 2, 3 & 4 of Affidavit-in-Opposition) dated

09.02.2020 d‡j Awf‡hv‡M AvbxZ NUbvi mgq AÎ †imcb‡W›Uc−rl

PvKzixB nqwb|

19| 2q Awf‡hvM GB †h, AÎ †imcb‡W›Uc−rl MvwdjwZi Kvi‡b WªvM gvgjv

bs 03/09 Gi AvmvgxMY LvjvmcÖvß n‡q‡Qb| †h‡nZz D³ Lvjv‡mi wel¦−Ü

miKvi fr  gnvgvb¨ nvB‡Kv‡U© 01/17 gvgjv `v‡qi K‡i‡Qb hv GL‡bv wePvivaxb Av‡Q †m‡nZz D³ wePvwiK Av`vj‡Zi iv‡qi Av‡jv‡K D³

AvcxjKvixi wel¦−Ü e¨e¯ v’ †bIqv m¤ú~Y© †eAvBbx, b¨vq wePvi ewnf©~Z Ges AÎ †imcb‡W›U c‡rl r¢a Kivi gvb‡m|

20| ‡h‡nZz wefvMxq gvgjvq ac¿¹ p¡−f−r AÎ †imcb‡W›U frNZ−L Ae¨vnwZ

cÖ`vb Kiv n‡q‡Q †m‡nZz D³ Ae¨vnwZi¢hl¦−Ü pÇf¤lL l¦m lre£u b‡n|

Kvib m¤ú~iK l¦m ac¿¹ KwgwUi cÖvß ac¿¹ cÖwZ‡e`b‡K E−fr¡ Ki‡Z cv‡i

bv|

Gg. mvBdDwÏb ‡LvKb GW‡fv‡KU, evsjv‡`k mycÖxg‡KvU©

‡imcb‡W›U bs- 10 I 11 Gi c‡¶

Ef-p¢Qh (Seü¡ÙÛÉ), ü¡ÙÛÉ J f ¢lh¡l LmÉ¡Z j¿»Z¡mu LaѪL ¢hNa Cw−lS£ 14.10.1997 a¡¢l−Ml pÈ¡lL ew- K,fÐ/¢X-26/87/35 ¢e−jÀ A¢hLm Ae¤¢mMe q−m¡x

NZf ÐS¡a¿»£ h¡wm¡−cn plL¡l

ü¡ÙÛÉ J f¢lh¡l LmÉ¡Z j¿»Z¡mu

Seü¡ÙÛÉ-1, n¡M¡z

14.10.97 ew- K,fÐ/¢X-26/87/35  a¡¢lMx 28.01.91

plL¡l Kod (¢eu¿»Z) AdÉ¡−cn, (AØfø) Hl 24ew d¡l¡ Ae¤k¡u£ N¢Wa S¡a£u Kod Ef−cø¡ f¢loc ¢ejÀl©f i¡−h f§eNÑWe L¢l−mez

12.             L¢j¢Vl NWex

1z l¡øÌf¢a - −Qu¡ljÉ¡ez 2z j¿»£/Ef−cø¡, f¢lLÒfe¡ j¿»Z¡mu - pcpÉz

3z j¿»£/Ef−cø¡, ü¡ÙÛÉ J f¢lh¡l LmÉ¡Z - pcpÉz

j¿»Z¡mu

4z  j¿»£/Ef−cø¡, ¢nÒf j¿»Z¡mu  -  pcpÉz

5z  j¿»£/Ef−cø¡, h¡¢ZSÉ j¿»Z¡mu  -  pcpÉz

6z  l¡øÌf¢al j¤MÉ p¢Qh  -  pcpÉz

7z  p¢Qh, ü¡ÙÛÉ J f¢lh¡l LmÉ¡Z j¿»Z¡mu  -  pcpÉ-p¢Qhz 8z  jq¡f¢lQ¡mL, H, Hj, Hp  -  pcpÉz

9z  −jSl ®Se¡−lm B¢ep Ju¡CS  -  pcpÉz

10z  AdÉ¡fL Hj, H, L¡−cl£  -  pcpÉz

11z  AdÉr Y¡L¡ ¢Q¢Lvp¡ jq¡¢hcÉ¡mu  -  pcpÉz

12z  fÐ−gpl (X¡x) Hp, Hj, ®q¡−pe  -  pcpÉz

13.              L¢j¢Vl L¡kÑf¢l¢dx

1.              S¡a£u Kod e£¢a h¡Ù¹h¡u−e plL¡l LaѪL ¢h¢iæ pj−u

Nªq£a fc−r−fl hÉ¡f¡−l fl¡jnÑ fÐc¡ez

2.              ÙÛ¡e£u  Kod  ¢n−Òf  Evp¡q  fÐc¡e  Hhw  ®c−nl  Q¡¢qc¡ ¢jV¡Ch¡l SeÉ Sl¦l£ Evf¡ce J plhl¡−ql ¢ho−u fl¡jnÑ fÐc¡ez
3.              Kod Hhw ®iod âhÉ (AØfø) hÉ¡f¡−l fl¡jnÑ fÐc¡ez
4.              Kod  Evf¡ce,  Bjc¡e£,  ¢hale  Hhw  ¢hœ²−ul  pw−N pw¢nÔø (AØfø) pwÙÛ¡ Hhw j¿»Z¡m−ul j−dÉ pjeÄu l¡M¡l hÉ¡f¡−l fl¡jnÑ fÐc¡ez

14.              ü¡ÙÛÉ J f¢lh¡l LmÉ¡Z j¿»Z¡m−ul (AØfø) f¢lcçl (AØfø)

L¡−S fÐ−u¡Se£u pq¡ua¡ fÐc¡e L¢l−hz

HC B−cn A¢hm−ð L¡kÑLl qC−hz

l¡øÌf¢al B−cnœ²−j

ü¡/- AØfø

(®j¡x BSq¡l¦m Cpm¡j) Ef-p¢Qh (Seü¡ÙÛÉ)

fСfL,

¢eu¿»L,

h¡wm¡−cn plL¡l£ j¤âe¡mu

−aSNy¡J ¢nÒf Hm¡L¡

Y¡L¡-1208z

(®N−S−Vl flhaÑ£ pwMÉ¡u fÐbj M−ä fÐL¡−nl SeÉ)z

Kod ¢eu¿»Z LaѪf−r l jq¡f¢lQ¡m−Ll fœ ¢e−jÀ A¢hLm Ae¤¢mMe

q−m¡x

DRUG CONTROL COMMITTEE

Drug Control Committee has been formed as per The Drug (Control) Ordinance, 1982, Section 4(1), And dated

on the 19th October, 2009 The Drug Control Committee amended and revised vide the memo No. Seü¡ÙÛÉ-1/Kod- 4/2008/372, a¡¢lMx 19.10.2009.

The jurisdiction of the 21 member committee are as follows:

1.   The Drug Control Committee will perform their duty

as per the Drug (Control) Ordinance 1982, Section 4(2), 5(2), 6(2) and 6(3).

2.     Any  other  specific subjects that  would be notified under this Ordinance or rule made under this Ordinance. The relevant sections of The Drug (Control) Ordinance are:

4. Drug Control Committee:

1.             The Government shall constitute a Drug Control Committee consisting of a Chairman and such other members as it may appoint from time to time.
2.             The Committee shall perform such functions as are specified in this Ordinance. 

5. Registration of Medicines:

1.             No medicine of any kind shall be manufactured for sale or be imported, distributed or sold unless it is registered with the licencing authority.
2.             The licencing authority shall not register a medicine unless such registration is recommended by the Committee.
3.             A registration shall be granted on such conditions as may be specified by the licencing authority. 
4.             A registration shall, unless cancelled earlier, be valid for a period of five years.

6. Cancellation or suspension of registration:

1.             The licencing authority may cancel the registration of any medicine if such cancellation is recommended by the Committee.
2.             The Committee shall evaluate every medicine registered before the commencement of this Ordinance and every medicine that may be manufactured or imported after such commencement in order to determine its safety, efficacy and usefulness.
3.             If on such evaluation the Committee finds that any such medicine is not safe, efficacious or useful it may recommend to the licencing authority cancellation of registration of the medicine.
4.             The licencing authority may, if it is satisfied that a medicine is substandard, suspend the registration of such medicine till he is satisfied that the medicine has attained its standard.

The activities of the Drug Control Committee (DCC) of the last two years.

1. Number of meeting : 1 (238th Meeting)
2. Date of Meeting : 22th October 2009
3. The following decisions were taken in the 238th Meeting:

1.   Regarding  the registration of 0.45% NaC1 IV Infusion Decision: The captions “Not permitted for the children” and “Only be used as per the recommendation of specialized physician” would be printed over the packing materials as condition of marketing of 0.45% NaCI IV Infusion. Registration of 0.45% NaCI IV Infusion has been approved.
2.   Regarding  the continuation of products containing Tacrolimus, Pimecrolimus & Hydroquinone

Decision: The registration of the products containing Tacrolimus, Pimecrolimus & Hydroquinone would be existed.

C.   Regarding the approval of different combination of vitamins and minerals: Among the 16 different combinations of vitamins and minerals 3 combination were approved and 13 rejected.

D.   Antioxidant preparation (Vitamin A + C + E)- Multiple Vitamin-Mineral Combinations/Individual Minerals/Varieties of combination of hematinics with micronutrients To examine the recommendations made by the committee formed before on the above combinations as expert committee has been formed to submits their reports with opinion to the Technical Sub-Committee of DCC.

E.    Product for local manufacture (Human)

*                   190 products approved.

*                   174 products rejected.

*                   For 25 products instructed to reply with necessary acceptable references and safety related documents.

*                   A committee has been formed for three products to evaluate safety, efficacy and usefulness and to submit report with data, elaborate documents to Technical Sub-Committee of DCC.

F.    Products for local manufacture (Veterinary)

*                   20 products approved.

*                   1 product rejected.

G.   Products for Importation (Human)

*                   55 products approved.

*                   37 products rejected.

*                   For 8 products instructed to reapply with sufficient documents and papers.

*                   Palce again to TSC-1 product.

H. Products for Importation (Veterinary)

*                   73 products approved.

*                   24 products rejected.

*                   To give opinion on one product to place in the next meeting of Technical Sub-Committee.

*                   To reaply-1 product.

I.     Medical Device for Local Manufacture

*                   2 products were approved.

J.     Surgical equipments for import

*                   5 products were approved.

K. Gauze and Bandage

*                   6 products approved.

*                   5 products rejected.

L.  Regarding the Registered Drugs of which the DCC approval references are not available

*                   Human Drugs: 223

*                   Veterinary Drugs: 195

*                   Imported Human Drugs: 34

Decision: Would be considered as approved by DCC.

13. Procedure for fast track registration of imported pre- qualified vaccines for use in Nation Immunization Program Decision: For the vaccines collected by UN agency the fast track registration guideline which has been finalized by DDA, DGHS, UNICEF, EPI, WHO, PH (DTL), CMSD approved.
14. Regarding the Free Sale Certificate (F. S. C) for importation of veterinary drugs Decision: The F. S. C. from any of the developed 24 countries as fixed before will be continued.
15. Regarding imported veterinary vaccines of same strength from different sources with different concentration

Decision: Application of such vaccines would be presented in DCC meeting.

Enclosure:

1.  The minutes of the 238th DCC Meeting is enclosed.

Sd/- Illegible

Maj Gen Md. Abul Kalam Azad

Director General

Directorate General of Drug Administrating

&

Licencing Authority Drugs                    Government of the Peoples Republic of Bangladesh

−Xf¤¢V ®l¢SØVÌ¡l, q¡C−L¡VÑ ¢hi ¡N, h¡wm¡−cn p¤fУj ®L¡VÑ Hl ¢hNa Cw−lS£ 08.12.2010 a¡¢l−Ml fœ¢V ¢e−jÀ A¢hLm Ae¤¢mMe q−m¡x

h¡wm¡−cn p¤fУj ®L¡VÑ

q¡C−L¡VÑ ¢hi¡N, Y¡L¡z

pÈ¡lL ew- 24738 H,    a¡¢lMx 08.12.10 ¢MËx

¢houx h¡wm¡−cn p¤fУj ®L¡VÑ, q¡C−L¡VÑ ¢hi¡−N l£V j¡jm¡ eðl

9105/2010 Hl 03.11.2010 ¢MËx a¡¢l−Ml B−c−nl ¢e−cÑne¡ Ae¤k¡u£ ®iS¡m Kod h¡ ®j¢X−Lm ¢fÐf¡−lne hå Ll¡l ¢ho−u j¢eV¢lw N¡CXm¡Ce °al£l SeÉ N¢Wa EµQ rja¡ pÇfæ L¢j¢V−a ®Sm¡ J c¡ul¡ SS, Y¡L¡-®L A¿¹iѧš² e¡ Ll¡ ¢ho−u L¡kÑLl hÉhÙÛ¡

NËqZ fÐpw−Nz

p§œx BCe j¿»Z¡m−ul pÈ¡lL ew- 830-¢hQ¡l-3/2 Hj-14/88(Awn),

a¡¢lMx 24.11.2010 ¢MËxz

EfkѤš² ¢hou J p§−œl ®fТr−a ¢e−cÑ¢na q−u j−q¡c−ul pcu AhN¢a J fÐ−u¡Se£u hÉhÙÛ¡ NËq−Zl SeÉ ¢he£ai¡−h S¡e¡−e¡ k¡−µR ®k, h¡wm¡−cn p¤fУj ®L¡VÑ, q¡C−L¡VÑ ¢hi¡−Nl 9105/2010 eðl l£V j¡jm¡u

Na 03.11.2010 ¢MËx a¡¢l−Ml B−c−n ®iS¡m Kod h¡ ®j¢X−Lm ¢fÐf¡−lne hå Ll¡l ¢ho−u j¢eV¢lw N¡CXm¡Ce °al£l SeÉ N¢Wa EµQ

rja¡ pÇfæ L¢j¢V−a ®Sm¡ J c¡ul¡ SS, Y¡L¡-®L A¿¹iѧš² Ll−Zl ¢ho−u

¢cL ¢e−cÑne¡ l−u−Rz

2z E¢õ¢Ma l£V j¡jm¡l 03.11.2010 ¢MËx a¡¢l−Ml B−c−n E−õM Ll¡ qu, “The Respondent No. 1 and 2 is hereby

directed to form a high power committee within fifteen

days consisting of all the respondents along with other

experts in the field to formulate monitoring guidelines in

order to stop adulteration of drug of medical preparation.” (L¢f pwk¤š²)z

3z E−õMÉ ®k, ®Sm¡ J c¡ul¡ SS, Y¡L¡ E¢õ¢Ma l£V j¡jm¡l 8

eðl Respondent.

4.  BCe, ¢hQ¡l J pwpc ¢houL j¿»Z¡mu q−a p§−œ¡¢õ¢Ma

pÈ¡lLk¤š² f−œl p¡−b ü¡ÙÛÉ J f¢lh¡l LmÉ¡Z j¿»Z¡mu, Seü¡ÙÛÉ-1 n¡M¡

q−a ®fТla fœ J pw¢nÔø L¡NS f−œl Ae¤¢m¢f ®fÐlZ f§hÑL ®iS¡m Kod

h¡ ®j¢X−Lm ¢fÐf¡−lne hå Ll¡l ¢ho−u j¢eV¢lw N¡CXm¡Ce °al£l SeÉ

N¢Wa EµQ rja¡ pÇfæ L¢j¢V−a ®Sm¡ J c¡ul¡ SS, Y¡L¡-®L A¿¹iѧš²

Ll−Zl ¢ho−u Aœ ®L¡−VÑl fl¡jnÑ j¿»Z¡mu−L Ah¢qa Ll¡l SeÉ Ae¤−l¡d

Ll¡ q−m H ¢ho−u j¡ee£u fÐd¡e ¢hQ¡lf¢a j−q¡cu ¢ejÀl©f A¢ija fÐc¡e

L−lex

“Let the learned Attorney General make a request

to the Learned Court to exonerate the District

Judge from the Committee.”

5z Hja¡hÙÛ¡u, j¡ee£u fÐd¡e ¢hQ¡lf¢a j−q¡c−ul A¢ifСu Ae¤k¡u£, ®Sm¡ J c¡ul¡ SS, Y¡L¡-®L E¢õ¢Ma L¢j¢V q−a AhÉ¡q¢a fÐc¡−el ¢ho−u L¡kÑLl hÉhÙÛ¡ NËq−Zl SeÉ ¢e−cÑ¢na q−u Bfe¡−L p¢heu Ae¤−l¡d Ll¡ qmz

ü¡/- AØfø 08/12/2010

(®nM q¡¢gS¤l lqj¡e)

−Xf¤¢V ®l¢SØVÌ¡l-2 −g¡ex 9570991z

pwk¤¢š²x hZÑe¡ ®j¡a¡−hLz

L¡kÑ¡−bÑx ¢h‘ HÉ¡VZÑ£ ®Se¡−lm gl h¡wm¡−cnz ü¡lL ew-            H,             a¡¢lMx              ¢MËx

Ae¤¢m¢f pcu AhN¢al J fÐ−u¡Se£u hÉhÙÛ¡ NËq−Zl SeÉx 1z p¢Qh, BCe J ¢hQ¡l ¢hi¡N, BCe, ¢hQ¡l J pwpc ¢houL j¿»Z¡mu, h¡wm¡−cn p¢Qh¡mu, Y¡L¡z

(®j¡q¡Çjc B¢ep¤l lqj¡e)

fÐbj pqL¡l£ ®l¢SØVÌ¡l

…l¦aÅf§ZÑ ¢hd¡u e¡l¡uN” ®Sm¡ J c¡ul¡ SS Hhw XÊ¡N Bc¡m−a c¡−ulL«a XÊ¡N ®LCp ew- 02/2009 j¡jm¡l Bl¢S ¢e−jÀ A¢hLm Ae¤¢mMe q−m¡x

−j¡L¡j ®Sm¡ J c¡ul¡ SS Hhw XÊ¡N Bc¡ma, e¡l¡uZN”

XÊ¡N ®LCp ew- 02/2009

l¡−øÌl f−r

e¡u¡l p¤ma¡e¡

Kod ašÆ¡hd¡uL

Kod fÐn¡pe

S¡jam¡, ¢eE Q¡o¡s¡, e¡l¡N”z

---------- h¡c£z

-he¡j-

1z Se¡h ¢jS¡e¤l lqj¡e

hÉhÙÛ¡fe¡ f¢lQ¡mL −jp¡pÑ ¢lX g¡jÑ¡ ¢mx ¢fa¡- Bmq¡S Bë¥m Sî¡l ¢h¢pL, e¾cef¤l

b¡e¡- hСþeh¡s£u¡ pcl

−Sm¡- hСþeh¡s£u¡z 2z −hNj ¢nEm£ lqj¡e

f¢lQ¡mL

−jp¡pÑ ¢lX g¡jÑ¡ ¢mx ü¡j£- Se¡h ¢jS¡e¤l lqj¡e ¢h¢pL, e¾cef¤l

b¡e¡- hСþeh¡s£u¡ pcl

−Sm¡- hСþeh¡s£u¡z 3z Se¡h ®j¡x Bë¥m N¢e

f¢lQ¡mL

¢jp¡pÑ ¢lX g¡jÑ¡ ¢mx ¢fa¡- jªa B¢ep¤l lqj¡e ¢h¢pL, e¾cef¤l b¡e¡- hСþeh¡s£u¡ pcl −Sm¡- hСþeh¡s£u¡z

4z Se¡h j¡qh¤h¤m Cpm¡j

g¡jÑ¡¢pø, ®l¢Sx ew- H-2391 −jp¡pÑ ¢lX g¡jÑ¡ ¢mx ¢h¢pL, e¾cef¤l

b¡e¡- hСþeh¡s£u¡ pcl −Sm¡- hСþeh¡s£u¡z

5z Se¡h He¡j¤m qL

g¡jÑ¡¢pø, ®l¢Sx ew- H- 2548 −jp¡pÑ ¢lX g¡jÑ¡ ¢mx ¢h¢pL, e¾cef¤l

b¡e¡- hСþeh¡s£u¡ pcl −Sm¡- hСþeh¡s£u¡z

--------- Bp¡j£z

 OVe¡l ÙÛ¡ex

−jp¡pÑ Bm-B¢je g¡−jÑp£

−fСf¡CV¡lx h¡µQ¤ ¢ju¡, Bs¡Cq¡S¡l h¡S¡l

Ef−Sm¡- Bs¡Cq¡S¡l, ®Sm¡- e¡l¡ueN”z

OVe¡l a¡¢lMx 23.07.2009z

d¡l¡x 16 (¢p) J 19 Kod ¢eu¿»Z BCe, 1982z

p¡r £x

1z h¡µQ¤ ¢ju¡, ¢fa¡- jªa BpLl Bm£, −fСf¡CV¡l- −jp¡pÑ Bm-

B¢je g¡−jÑp£, Bs¡Cq¡S¡l h¡S¡l, Ef−Sm¡- Bs¡Cq¡S¡l,

−Sm¡- e¡l¡ueN”z

2z Se¡h ®j¡x n¢gL¥m Cpm¡j, Kod ašÆ¡hd¡uL, Kod fÐn¡pe,

f¢lcçl, Y¡L¡z

3z X¡x ®j¡x Bh¤ hLl ¢p¢ŸL, plL¡l£ ¢h−nÔoL, XÊ¡N ®V¢øw

mÉ¡h−lVl£, Seü¡ÙÛÉ Ce¢ø¢VEV, jq¡M¡m£, Y¡L¡- 1212z

h¡c£ f −r ¢e−hce HC ®k,

1z h¡c£ Kod ašÆ¡hd¡uL, Kod fÐn¡pe, e¡l¡uZN” (NZfÐS¡a¿»£

h¡wm¡−cn plL¡l)-H LjÑlaz

2z 1, 2 J 3ew Bp¡j£ M/S RID Pharma Ltd.,  ¢h¢pL,

e¾cef¤l, b¡e¡- hСþeh¡s£u¡ pcl, ®Sm¡- hСþeh¡s£u¡z kb¡œ²−j hÉhÙÛ¡fe¡ f¢lQ¡mL J f¢lQ¡mL Hhw 4 J 5ew Bp¡j£ Eš²

M/S. RID Pharma Ltd. Hl g¡jÑ¡¢pøz

3z h¡c£ e¡l¡ueN” A’−m LjÑla b¡L¡L¡−m ®c−nl ¢h¢iæ ¢V¢i

QÉ¡−em J NZ j¡dÉ−jl fÐL¡¢na, fÐQ¡¢la Y¡L¡ ¢nö q¡pf¡a¡−ml

¢nö ®l¡N ¢h−no‘NZ fÐL¡j L−le ®k, Bp¡j£−cl j¡¢mL¡e¡d£e

M/S. RID Pharma Ltd.  Hl  Temset Syrup/Suspension (Paracetamol) & Ridaplex

Syrup (Vitamin B Complex)  ®ph−e ¢nö−cl ¢LXe£

A−L−S¡ qCu¡ ¢nö jªa¥É O¢V−a−Rz Eš² pwh¡ cl fТa plL¡−ll cª¢ø BL«ø qu Hhw HC ¢ho−u …l¦aÅ Ae¤d¡he L¢lu¡ Kod fÐn¡pe f¢lcçl a¡vr¢ZLi¡−h Seü¡−ÙÛÉl ü¡aÑ ¢h−hQe¡ L¢lu¡ ¢h¢iæ °c¢eL pwh¡c ¢h‘¢ç à¡l¡ Sep¡d¡lZ−LM/S. RID Pharma

Ltd.  Hl Evf¡¢ca  Temset Syrup/Suspension &

Ridaplex Syrup ®ph−e ¢hla b¡¢Lh¡l SeÉ paLÑ L−lez

4z f¢lQ¡mL, Kod fÐn¡pe f¢lcçl, Y¡L¡-Hl ¢e−cÑnœ²−j h¡c£ Bp¡j£−cl j¡¢mL¡e¡d£e M/S. RID Pharma Ltd.  Hl

Evf¡¢ca  Ridaplex Syrup & Temset Suspension/Syrup h¡S¡l qC−a pwNËq L¢lu¡ fl£r¡l SeÉ

¢e−cÑn fÐc¡e L¢l−m h¡c£ ¢hNa 23.07.2009 Cw a¡¢l−M 1ew p¡r£ ®jp¡pÑ Bm-B¢je g¡−jÑp£, ®fСf¡CV¡lx h¡µQ¤ ¢ju¡, Bs¡Cq¡S¡l h¡S¡l, Ef−Sm¡- Bs¡Cq¡S¡l, ®Sm¡- e¡l¡ueN”

®c¡L¡e qC−a Temset Suspension/Syrup, Batch No. 05

Së L−le Hhw f¢lQ¡mL, Kod fÐn¡pe f¢lcçl, Y¡L¡-Hl ¢eLV fÐ−u¡Se£u hÉhÙÛ¡ NËq−Zl SeÉ Sj¡ fÐc¡e L−lez Kod fÐn¡pe f¢lcçl qC−a Se¡h ®j¡x n¢gL¥m Cpm¡j, Kod ašÆhd¡uL ej¤e¡¢V Test & Analysis  Hl SeÉ Kod fÐn¡pe f¢lcçl

pÈ¡lL ew- ¢XH/Hp¢X/n¢gL/6847 a¡¢lM 27.07.2009 XÊ¡N ®V¢øw mÉ¡h−lVl£, Seü¡ÙÛÉ Ce¢ø¢VEV, jq¡M¡m£, Y¡L¡u ®fÐlZ

L−lez

5z XÊ¡N ®V¢øw mÉ¡h−lVl£, jq¡M¡m£, Y¡L¡ ¢e−jÀh¢ZÑa pÈ¡lL ®j¡a¡−hL

Bp¡j£−cl Evf¡¢ca-

Temset Suspension/Syrup, Batch No. 05  fl£r¡ J

¢h−nÔoe L¢lu¡ pÈ¡lL ew- ¢X¢VHm/1969/09/1471 a¡¢lM 29.07.2009 fc¢Vl Diethylene Glycol Hl Ef¢ÙÛ¢a pe¡š²

L−lez Diethylene Glycol  HL¢V ¢ho¡š² ®L¢jLÉ¡m k¡q¡ ®ph−e j¡e¤−ol jªa¥É O¢V−a f¡−lz HC S¡a£u fc¡bÑ p¡d¡lZa ®Ve¡l£ J X¡Cw gÉ¡ƒl£−a hÉhq©a quz Eš² SëL«a Temset Suspensions/Syrup  H Paracetamol  Hl f¢lj¡Z 120